id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-D-0301-0016,FDA,FDA-2004-D-0301,Fixed-Combinations and Single-Entity Versions of Previously Approved Antiretrovirals for the Treatment or Prevention of Human Immunodeficiency Virus-One Under the President’s Emergency Plan for Acquired Immunodeficiency Syndrome Relief; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2023-08-03T04:00:00Z,2023,8,,,2023-08-03T15:26:30Z,2023-16557,0,0,0900006485db567f
FDA-2004-D-0301-0015,FDA,FDA-2004-D-0301,Fixed-Combinations and Single-Entity Versions of Previously Approved Antiretrovirals for the Treatment or Prevention of HIV-1 Under PEPFAR - Guidance for Industry DRAFT GUIDANCE,Other,Guidance,2023-08-01T04:00:00Z,2023,8,2023-08-01T04:00:00Z,2023-11-02T03:59:59Z,2024-11-07T00:32:52Z,,1,0,0900006485d9dba5